Physician

Richard F. Spaide, MD

According to 2025 Medicare claims, Richard Spaide, MD (NPI: 1730281957) practices ophthalmology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from New York, NY. This provider's primary affiliated billing organization is VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK (NPI: 1598700791; TIN: 132721177) and primary practice location at 10022-2705.

Spaide's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 799 traditional Medicare patients, billed 60,981 HCPCS/CPT codes, and received $2,305,506 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 268 prescription claims across 102 beneficiaries totaling $28,456 in drug costs, led by Alphagan P (Brimonidine Tartrate). Open Payments data shows 19 records totaling $212,404. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $69,550 to $28,456. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.3M2015 Medicare payment: $1,970,595 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,096,774 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,921,098 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,061,251 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,993,491 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,808,651 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,015,152 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,208,113 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,059,270 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,305,506 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201561110,069$1,970,595
201666311,081$2,096,774
201768510,413$1,921,098
201871911,007$2,061,251
201966310,555$1,993,491
20206278,432$1,808,651
20216519,238$2,015,152
202263014,379$2,208,113
202371638,503$2,059,270
202479960,981$2,305,506

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$35K$70K2015 Drug cost: $69,550 (USD; Tot_Drug_Cst)2016 Drug cost: $70,114 (USD; Tot_Drug_Cst)2017 Drug cost: $66,980 (USD; Tot_Drug_Cst)2018 Drug cost: $28,300 (USD; Tot_Drug_Cst)2019 Drug cost: $12,330 (USD; Tot_Drug_Cst)2020 Drug cost: $30,299 (USD; Tot_Drug_Cst)2021 Drug cost: $21,803 (USD; Tot_Drug_Cst)2022 Drug cost: $14,118 (USD; Tot_Drug_Cst)2023 Drug cost: $31,412 (USD; Tot_Drug_Cst)2024 Drug cost: $28,456 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015162505$69,550
2016147418$70,114
201767182$66,980
201852127$28,300
20193670$12,330
202097202$30,299
202154134$21,803
20224292$14,118
202375178$31,412
2024102268$28,456

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system363401$108
92012Established patient problem focused exam of visual system3921,317$82
92134Imaging of retina7761,874$37
92250Photography of the retina616682$33
92202Extended exam of the back part of the eye with optic nerve drawing298732$14

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Alphagan PBrimonidine Tartrate11519$3,220
Bromfenac SodiumBromfenac Sodium14400$2,533
Prednisolone AcetatePrednisolone Acetate321,303$1,194
TravoprostTravoprost15438$1,156
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol14427$1,030

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.19$212,404Topcon Healthcare, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Richard F. Spaide, MD?

Tedicare shows public-source Medicare data for Richard F. Spaide, MD (NPI 1730281957), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard F. Spaide, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Richard F. Spaide, MD?

Richard F. Spaide, MD is linked to VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK (billing NPI 1598700791) in the available physician profile data.

Does Richard F. Spaide, MD have Open Payments data?

Richard F. Spaide, MD has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.